Top 50 Life Science VC Funds & Investors in Canada (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
FACIT
VC Fund
|
8 | Canada, United States | Seed, Pre-Seed | Biotechnology, Health Care, Medical | $1M–$8M |
|
Real Ventures
VC Fund
|
6 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $650k–$50M |
|
E-Fund
VC Fund
|
5 | Canada, China, United States | Seed, Pre-Seed | Health Care, Medical, Medical Device | $256k–$4.2M |
|
Amplitude Venture Capital
VC Fund
|
5 | Canada, United States, Israel | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.9M–$85M |
|
Anges Quebec
VC Fund
|
4 | Canada, Spain, United States | Seed, Angel | Software, Health Care, Artificial Intelligence | $366k–$3.1M |
|
Ontario Centre of Innovation
VC Fund
|
4 | Canada, United States | Seed, Pre-Seed, Grant | Health Care, Medical, Software | $7.3k–$3.1M |
|
Apjohn ventures
VC Fund
|
4 | United States, Canada | Series A, Series C | Health Care, Biotechnology, Life Science | $2.5M–$39M |
|
Radical Ventures
VC Fund
|
4 | United States, Canada, United Kingdom | Seed, Series A, Series B | Artificial Intelligence, Software, Information Technology | $1.8M–$200M |
|
Golden Ventures
VC Fund
|
3 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.5M–$47M |
|
Afore Capital
VC Fund
|
3 | United States, Canada, India | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $535k–$23M |
|
MEDTEQ+
VC Fund
|
3 | Canada | Seed, Series A | Health Care, Medical Device, Biotechnology | $350k–$18M |
|
Panache Ventures
VC Fund
|
3 | Canada, United States, Israel | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $717k–$20M |
|
Toronto Innovation Acceleration Partners
VC Fund
|
3 | Canada, United States | Pre-Seed, Seed | Health Care, Biotechnology, Software | $22k–$8M |
|
GreenSky Ventures
VC Fund
|
3 | Canada, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $675k–$4.4M |
|
iGan Partners
VC Fund
|
3 | Canada, United States, United Kingdom | Seed, Series A | Health Care, Software, Medical | $1.9M–$17M |
|
Innovacorp
VC Fund
|
3 | Canada, Australia, United States | Seed, Grant, Pre-Seed | Software, Information Technology, Health Care | $18k–$3.1M |
|
Accelerate Fund
VC Fund
|
2 | Canada, United States | Seed, Series A | Software, Health Care, Medical | $951k–$12M |
|
WUTIF
VC Fund
|
2 | Canada | Seed, Pre-Seed, Series A | Software, Health Care, Biotechnology | $100k–$3.8M |
|
Sustainable Development Technology Canada
VC Fund
|
2 | Canada, United States, Brazil | Grant, Seed | Manufacturing, Energy, Software | $73k–$6.2M |
|
BDC Venture Capital
VC Fund
|
2 | Canada, United States, Japan | Series A, Seed | Software, Information Technology, Artificial Intelligence | $603k–$16M |
|
Fonds de solidarité FTQ
VC Fund
|
2 | Canada, United States, Israel | Series A, Series B | Manufacturing, Biotechnology, Software | $2.2M–$83M |
|
Page One Ventures
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Series B, Pre-Seed | Software, Artificial Intelligence, Information Technology | $500k–$130M |
|
Resolve Growth Partners
VC Fund
|
2 | United States, Canada | Series A, Series B | Software, SaaS, Information Technology | $7.5M–$21M |
|
Versant Ventures
VC Fund
|
2 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.7M–$108M |
|
Ramen Ventures
VC Fund
|
2 | Canada, United States | Seed, Pre-Seed, Angel | Biotechnology, Health Care, Software | $120k–$3.2M |
|
Ontario Centres of Excellence
VC Fund
|
2 | Canada, United States | Seed, Grant, Pre-Seed | Software, Information Technology, Health Care | |
|
Charles River Laboratories International
VC Fund
|
2 | United States, Canada, France | Series A, Series B | Biotechnology, Health Care, Life Science | $12M–$103M |
|
ScaleGood Fund LP (powered by TELUS)
VC Fund
|
2 | Canada | Pre-Seed, Seed | Health Care, Wellness, Apps | $37k–$5.2M |
|
Pfizer Venture Investments
VC Fund
|
2 | United States, United Kingdom, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $10M–$123M |
|
Desjardins Venture Capital
VC Fund
|
2 | Canada, United States | Seed, Series A | Software, Information Technology, Manufacturing | $805k–$22M |
|
LVL1 Group
VC Fund
|
2 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, Apps | $577k–$39M |
|
Innovate Calgary
VC Fund
|
2 | Canada, United States | Seed, Pre-Seed | Health Care, Medical, Medical Device | $73k–$1.9M |
|
Angel Forum
VC Fund
|
2 | Canada, United States | Seed, Angel, Pre-Seed | Biotechnology, Software, Health Care | $20k–$500k |
|
Two Small Fish Ventures
VC Fund
|
2 | Canada, United States, Trinidad and Tobago | Seed, Series A | Software, Artificial Intelligence, E-Commerce | $1.8M–$25M |
|
StandUp Ventures
VC Fund
|
2 | Canada, United States | Seed, Series A, Pre-Seed | SaaS, Software, Artificial Intelligence | $731k–$14M |
|
Yaletown Partners
VC Fund
|
2 | Canada, United States, Belgium | Series A, Series B, Seed | Software, Manufacturing, Enterprise Software | $603k–$31M |
|
Atlantic Canada Opportunities Agency
VC Fund
|
2 | Canada, United States, France | Grant, Debt Financing, Seed | Software, Manufacturing, Information Technology | $25k–$2M |
|
Hazelview Ventures
VC Fund
|
2 | Canada, Slovakia (Slovak Republic) | Seed, Pre-Seed | Software, Artificial Intelligence, Big Data | $2M–$12M |
|
1517 Fund
VC Fund
|
1 | United States, Canada, India | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | |
|
Negev Capital
VC Fund
|
1 | United States, Canada, Australia | Seed, Post-IPO Equity, Series A | Biotechnology, Health Care, Medical | |
|
Whitesell Group
VC Fund
|
1 | Canada | Seed | Software, Aerospace, Architecture | |
|
SeedFolio
VC Fund
|
1 | United States | Seed, Series A | Medical, Health Care, Biotechnology | |
|
Alexandria Venture Investments
VC Fund
|
1 | United States, France, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | |
|
Suffolk Technologies
VC Fund
|
1 | United States, United Kingdom, Canada | Seed, Series A, Series B | Construction, Software, Artificial Intelligence | |
|
Ontario Bioscience Industry Organization
VC Fund
|
1 | Canada | Seed, Grant | Biopharma, Biotechnology, Medical Device | |
|
Prelude Ventures
VC Fund
|
1 | United States, Canada | Series A, Series B, Series C | Software, Energy, Manufacturing | |
|
Eos BioInnovation
VC Fund
|
1 | ||||
|
Questa Capital Management
VC Fund
|
1 | United States, Canada, United Kingdom | Series B, Series C | Health Care, Medical Device, Medical | |
|
Archangel Network of Funds
VC Fund
|
1 | Canada | Seed, Pre-Seed | Health Care, Medical Device, Software | |
|
AgCapital Canada
VC Fund
|
1 | Canada | Seed, Series A, Series B | AgTech, Analytics, Internet of Things | |
| Access all 249 VC funds in Canada Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario's economy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 29
- Round size: Seed $1M–$8M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Esphera SynBio — Creating modified exosomes that can be designed to have targeting moieties on their surface and a variety of protein or RNA payloads in their lumen.
- Hyivy Health — Hyivy Health is working on the first smart pelvic health rehabilitation system for patients and the clinicians who treat them.
- HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
Real Ventures is an early-stage venture firm focused on serving daring entrepreneurs with the ambition to create successful, global companies. Since 2007, Real Ventures has dedicated itself to building the Canadian startup ecosystem on the belief that people, not money, build game-changing companies. Real Ventures provides stage-specific guidance,mentorship, and access to networks and resources to fast-track founders’ personal and company growth. Real Ventures manages $325 million across five funds and its active portfolio of 100+ companies is currently valued at $10 billion. www.realventures.com
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 209
- Round size: Seed $650k–$5M; Series A $2.2M–$22M; Series B $2.8M–$50M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $132M in 2017
Portfolio highlights
- Peggy — Peggy is a social marketplace that allows you to discover, buy, and sell investment-worthy art. A place for the art-curious and the art-expert, for the art gallery and artist. A new way forward for the art world.
- Clutch — Clutch is a Toronto-based technology company that is reinventing the way people buy and own cars. Clutch offers high-quality certified vehicles at great prices through a fully online customer experience. At Clutch.ca, customers browse inventory online, buy the car that’s right for them, and enjoy effortless at-home delivery. Clutch’s mission is toprovide customers with a delightful car buying experience by offering high-quality cars at great prices with ultimate convenience while making a positive impact on the communities in which it operates.
- Canvass AI — Canvass AI empowers industrial workforces to leverage data and create immediate impact in their day-to-day operations.
The E-Fund (VANTEC Entrepreneurs Fund VCC Inc.) was established in 2011 to invest in promising new ventures in British Columbia in a wide range of industry sectors. They are focused on co-investing with other angel investors and early-stage venture capital firms in seed-stage companies with high growth opportunities.The E-Fund involvesspecific investors in the investment due diligence process depending on their industry experience and knowledge and their particular technical expertise. It is their goal to become the ‘Go-to Braintrust’ for active and in-depth angel investing.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Canada, China, United States
Investor stats
- Total investments: 56
- Round size: Seed $474k–$4.2M; Pre-Seed $256k–$1M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- VoxCell BioInnovation — Creating an extraordinary line of solutions for the drug development industry and the field of Oncology research.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is developing novel RNA therapeutics for central nervous system disorders.
Amplitude Ventures is a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology. and AI
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 33
- Round size: Seed $6.6M–$12M; Series A $2.9M–$85M; Series B $35M–$83M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $146M in 2019
Portfolio highlights
- Deep Genomics — Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront.
- Thryv Therapeutics — LQT Therapeutics is a biopharmaceutical company discovering and developing SGK1 inhibition therapies for Long QT Syndrome and various cardiovascular diseases and cancers.
- Congruence Therapeutics — ABOUT US We are a drug discovery company that is uniquely harnessing the power of protein dynamics, biophysics, machine learning and computational chemistry. Our Science Traditional drug design is limited At Congruence,
Value-added investors for innovative entrepreneurs.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Angel
- Geography: Canada, Spain, United States
Investor stats
- Total investments: 155
- Round size: Seed $805k–$3.1M; Angel $366k–$1.3M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Zilia — Zilia's non-invasive assessment of biomarkers in the eye redefines the way we prevent, diagnose, and treat various diseases.
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- Gray Oncology Solutions — Gray Oncology Solution is a healthcare enterprise software company that commercializes GrayOS, the operating system for oncology.
Ontario Centre of Innovation provides a preeminent research-to-commercialization vehicle in Ontario
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 48
- Round size: Seed $366k–$3.1M; Grant $7.3k–$110k; Pre-Seed $146k–$2.3M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Talin — Supercharge your recruting process with Talin's AI powered tools.
- TROES — TROES is a Canadian company to develop smart power energy storage technologies, products, and solutions in a 170 Billion market to help middle-market project developers, power distributors, and power consumers to unlock numerous project opportunities with considerable payback which are not existed previously due to high project cost, lack ofexpertise and low development efficiency by using our patented modularized energy storage hardware and software.
- MIMOSA Diagnostics — MIMOSA Diagnostics is an m-health tech startup with a novel handheld device and integrated smartphone app for image visualization of skin health. MIMOSA is bringing medical grade technology out of hospitals and into the hands of patient consumers. The value proposition for MIMOSA’s AI diagnostic data warehouse will provide metadata insightsintegrated with patient EMR/EHR systems. Our first commercial entry launch is in the Diabetes sector, with future expansion to follow into other therapeutic areas.MIMOSA diagnostics puts the future of skin health into your hands. The MIMOSA is one of the few handheld multispectral skin imaging devices in the healthcare industry. Our proprietary algorithms risk profile the skin in various clinical settings. Our technology will allow healthcare to be equitable, efficient, and more personalized for all.
Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to invest primarily in early stage life sciences companies across the Midwest. The goal of the Fund is to provide investors with superior financial returns by making equity investments in innovative life sciences companies with sustainable and outstandinggrowth potential.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Life Science
- Stage:Series A, Series C
- Geography: United States, Canada
Investor stats
- Total investments: 15
- Round size: Series A $2.5M–$39M; Series C $3M–$34M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Tetra Discovery — Tetra Discovery Partners provides consulting services in drug discovery and development. They partner with Universities to commercialize intellectual property and conduct proprietary research on diseases affecting the central nervous system.Their research focuses on developing new treatments for depression and schizophrenia. Severe forms ofdepression affect 2–5% of the US population, while mood disorders impact 7% of the world’s population and rank among the top ten causes of disability.
- Tetra Therapeutics — Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Fragile X syndrome, Alzheimer's disease, traumatic brain injury, and other brain disorders.
- Sierra Oncology — Sierra Oncology is late-stage clinical drug development biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer.
Radical Ventures invests in the future of how we live, work and play, partnering with founders who understand the transformational power of AI.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 119
- Round size: Seed $1.8M–$27M; Series A $7M–$53M; Series B $30M–$200M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
- Covariant — Covariant is a developer of artificial intelligence for robotics. Covariant is building the Covariant Brain, a universal AI to give robots the ability to see, reason and act on the world around them.
- Muon Space — Earth intelligence for a Safe and Resilient World.
Golden Ventures is a leading seed-stage venture capital fund, based in Toronto and investing across North America. We back bold teams and their transformative ideas.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 183
- Round size: Seed $1.5M–$7.5M; Series A $5.9M–$32M; Series B $14M–$47M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Cybrid — The Cybrid software development kit & cloud-based platform can enable you to launch crypto trading within weeks, for minimal fees. Save millions in headcount, legal, and operational costs, compared to building your own platform from scratch.
- BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
- Shakudo — Shakudo unites all of the data tools and services you need into a single comprehensive data platform, allowing your team to develop and deploy analytics-based solutions with ease.
Afore Capital backs product-centric founders at the pre-seed stage exclusively. The investment team brings 16 years of founding product experience (Android and Twitter) and 7 years of institutional investing experience (Founder Collective and Foundation Capital). Their sweet spot is the ~$1M pre-seed round, where they can lead the round as aninstitutional investor alongside high value angels.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 202
- Round size: Seed $2.2M–$10M; Pre-Seed $535k–$3M; Series A $7M–$23M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Openmart — AI agent that automates B2B sales for brands and manufacturers.
- Develop Health — Develop Health synthesizes patient data to automatically fill medication prior authorization forms. Save time and boost approval rates.
- Loop AI - Delivery Intelligence Platform — Fully automated delivery intelligence platform. Loop AI is your co-pilot to manage your food brand. Empower your team to minimize errors, stay ahead of food trends and boost revenue through data driven smart workflows.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!MEDTEQ is a non-profit organization for industrial research and innovation in medical technology. The organization accelerates the development of innovative technological solutions to improve patients’ health and quality of life by mobilizing Canadian talents. They bringing together the key players in healthcare and innovation allows them and theirpartners, to offer Canadians access to novel solutions.MEDTEQ’s mission is, through collaborative, industry-led projects, to accelerate innovation and position, on a global scale, products and services developed by the Canadian medical technologies industry.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Canada
Investor stats
- Total investments: 29
- Round size: Seed $350k–$4M; Series A $2.9M–$18M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- Eli — At-home hormone testing from Eli Health: track cortisol, progesterone, and testosterone with saliva tests that deliver lab-grade results in 20 minutes.
- LUCID — LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness.
- HALEO Clinic — HALEO is an online insomnia clinic that fits in your pocket
Canada's leading nationwide pre-seed venture fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 152
- Round size: Seed $1M–$6M; Pre-Seed $717k–$2.8M; Series A $5.7M–$20M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Revyl — Revyl is an observability platform that helps teams identify and resolve bugs before they reach production. It offers real-time monitoring and insights, allowing developers to catch issues early in the development process. With features such as error detection and performance analytics, Revyl enhances software reliability and improves the overalluser experience.
- Beatdapp — Beatdapp offers a tracking system that authenticates, verifies, and validates media streamed in real-time.The service reduces the tracking discrepancies between Digital Service Providers (DSPs) and rights holders, increasing royalty revenue for rights holders while limiting legal exposure to royalty lawsuits for DSPs. Think of it like a PWC formusic play count.
- MarketMuse — Our AI-powered software tells you what content to write (and how much) to leverage your experience and rank higher where competitors are weak.
MaRS Innovation (MI) is a commercialization engine that integrates, centralizes and accelerates time to market of the discovery and intellectual property assets from its 15 world-class research institutions. MI’s discovery and innovation pipeline is derived from $1 billion in annual R&D funding. Created as a not-for-profit organizationthrough the Government of Canada’s Center of Excellence for Commercialization and Research program (CECR), MI has raised $50 million from federal and provincial governments, member institutions and industry partners. MI’s vision is to transform the Toronto-based research enterprise into one of world’s most successful commercialization clusters.Through detailed, market facing due diligence, MI identifies opportunities from Canada’s largest academic cluster for further development and commercialization through project management, intellectual property management, investment and technology development. By crossing the innovation gap, MI transforms these opportunities into successful high-value licensing transactions and financeable start-up companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Pre-Seed, Seed
- Geography: Canada, United States
Investor stats
- Total investments: 60
- Round size: Seed $73k–$8M; Pre-Seed $22k–$525k
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
- Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
- Grey Matter Neurosciences — Grey Matter Neurosciences is a neurotechnology firm developing new medical devices and drug-device combinations to treat age-related brain illnesses like dementia.
GreenSky Ventures is a Toronto-based firm that makes investments in early-stage Canadian technology companies.GreenSky Ventures seeks early-stage B2B technology companies in Canada, emphasizing protectable IP and experienced management. It makes investments in early-stage technology companies through its affiliated venture capital funds, GreenSkyAccelerator Fund I, II and III. Their principals bring a unique combination of experience in technology, law, and finance to high-growth potential companies and dedicated entrepreneurs.GreenSky Capital was founded in Toronto, Ontario in 2010 by Geoff Simonett and Michael T. R. List.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 65
- Round size: Seed $675k–$3.3M; Series A $2.3M–$4.4M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Assetflo — Assetflo provides mobile IoT solutions for tracking the precise location from tracking applications.
- PhenoTips — More than just a pedigree maker, PhenoTips is a complete software solution for medical genomics, making your genomics department future-forward and paper-free.
- Trolley — Trolley is the best payouts platform for businesses needing to pay creators, musicians, artists, freelancers, or on-demand workers.
iGan Partners is one of Canada's largest healthcare-focused venture capital firms, investing across North America. We provide capital and expertise to scale innovative healthcare solutions.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 46
- Round size: Seed $1.9M–$5M; Series A $4M–$17M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Docsi — DOCSI provides preference card optimization, surgeon engagement and supply chain cost reduction through novel digital solutions.
- Cyborg — Introducing CyborgDB: The Confidential Vector Database. Keeps inference data end-to-end encrypted for unparalleled privacy & regulatory compliance.
- Cosm Medical — Cosm Medical is a VC-backed health-tech startup building and commercializing a software-enabled medical device platform to improve the lives of women affected by pelvic floor disorders.
Innovacorp is an early-stage venture capital firm that helps knowledge-based startups commercialize their technologies in the global marketplace. It invests in early stage Nova Scotia entrepreneurs, combining venture capital with business mentoring and incubation facilities. Innovacorp was established in 1995 and based in Halifax, Canada.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, Australia, United States
Investor stats
- Total investments: 155
- Round size: Seed $50k–$3.1M; Grant $25k–$91k; Pre-Seed $18k–$878k
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $40M in 2016
Portfolio highlights
- Bright Breaks — Bright offer on-site and virtual amenities for companies and employees. whether your team is on-site, working from home, or in between.
- Planetary — Planetary restores the chemistry of seawater so it can do what it has always done: support life and protect the planet.
- CarbonCure Technologies — CarbonCure Technologies creates, develops, and licenses solutions that consume waste CO2 to make better concrete. It spurs the market shift towards affordable green concrete, by enabling concrete manufacturers to convert waste CO2 into solid minerals, locked away as a solid within concrete during manufacturing. It is a green building technologycompany currently serving concrete product manufacturers in the US and Canada. It offers concrete producers the ability to manufacture green concrete products without compromising on either quality or price.CarbonCure is a retrofit innovation that repurposes CO2 gas from large final emitters as a feedstock in concrete plants. The gas is permanently converted into embedded solid mineral carbonates that yield material, environmental, and production advantages. By enabling concrete manufacturers to consume CO2 into concrete products during manufacturing, the technology differentiates an otherwise traditional commodity concrete product, while achieving superior material performance characteristics. In addition to technology, CarbonCure provides demand-pull marketing and environmental reporting/certification services to reinforce its customers’ exclusive competitive positioning. The technology is licensed at a very low-CAPEX to concrete producers, generating a recurring revenue stream.CarbonCure Technologies was founded in 2007 and is headquartered in Halifax, Nova Scotia.
Accelerate Fund supports the growth of early-stage Alberta technology companies with a multi million dollar fund that combines co-investment from angel investors.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 59
- Round size: Seed $1M–$6.6M; Series A $951k–$12M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $15M in 2020
Portfolio highlights
- Kiwi Grocery — Kiwi Grocery cuts out the grocery store and delivers direct to your door. That means you pay less for your groceries and save on costly service fees. Kiwi users save 35% on their grocery checkout totals compared to other delivery apps.
- Truffle — Truffle enables restaurants of all sizes to empower their teams, increase profits, and provide a smart dining experience that customers expect, with tools to manage your restaurant in a single platform. Truffle offers restaurants flexible tools to expand into Point of Sale, Online Ordering, Table Side, Delivery Management, Automated Pickup, TableReservations and Guest Marketing.
- Dryrun — From lightening fast data imports and automated forecasts, through to unmatched control to model out scenarios, Dryrun is the choice for CFOs managing cash flow for multi-million dollar businesses. Dryrun integrates with Sage Intacct, QuickBooks Online, Xero and Pipedrive.
WUTIF Capital (VCC) Inc. is a novel angel fund that co-invests with angel investors in promising new technology ventures in British Columbia. WUTIF was formed in mid-2003 and made its first investments in late 2004.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada
Investor stats
- Total investments: 73
- Round size: Seed $100k–$3.8M; Pre-Seed $256k–$1.2M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- Carbonyx — Carbonyx is a biotechnology company that transforms industrial waste into valuable byproducts while permanently storing carbon dioxide.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is developing novel RNA therapeutics for central nervous system disorders.
At Sustainable Development Technology Canada (SDTC), they fund Canadian cleantech projects and coach the companies that lead them as they move their ground-breaking technologies to market.SDTC’s support of cleantech translates into jobs, growth, and export opportunities for Canadian companies, as well as economic, environmental and healthbenefits for all Canadians. They are independent but don’t work alone. A big part of their role is building and sustaining networks of partners and stakeholders from private industry, academia and governments, at home and abroad. They operate at arm’s length and receive funding from the Government of Canada.
Show more...Investment focus
- Industry: Manufacturing, Energy, Software
- Stage:Grant, Seed
- Geography: Canada, United States, Brazil
Investor stats
- Total investments: 177
- Round size: Seed $73k–$1.7M; Grant $878k–$6.2M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Niricson — Niricson Software has developed a proprietary damage assessment software platform paired with a patent-pending drone-based data collection technology that helps infrastructure owners inspect their structures (e.g. hydro dams) in a way that is more accurate, five times faster, and 50% more cost-effective. Niricson is differentiated by its ability toautomatically detect and quantify not only surface damage, but also subsurface damage.
- Solaires Entreprises Inc — Solaires Entreprises Inc is a Canadian cleantech company located in Victoria, BC, that consists of a team of 23 scientists, engineers, and business professionals. Solaires is focused on developing the next generation of solar cells by replacing silicon with perovskite through an innovative and sustainable manufacturing process resulting inaffordable solar photovoltaics with higher energy conversion efficiency.
- Progressive Planet Solutions — Progressive Planet Solutions Inc is a metal/mineral based company that deals with the exploration & development of zeolite minerals.
BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on technology-based businesses that have high growth potential and that are positioned to become dominant players in their markets. The company helps create and develop strongCanadian businesses through financing, consulting services and securitization, with a focus on small and medium-sized enterprises.BDC Venture Capital has been involved in venture capital since 1975 and has to date invested in more than 400 companies involved in the areas of Life Sciences, Telecommunications, Information Technology and Advanced Technologies.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Canada, United States, Japan
Investor stats
- Total investments: 402
- Round size: Seed $603k–$5M; Series A $3.1M–$16M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Axonify — Axonify provides eLearning software, interval reinforcement solutions, and gamified learning. Using principles of interval reinforcement and incorporating the realities of how emerging workforces learn in today’s environment, Axonify enables its customers to make training stick and improve employee performance.
- RainStick — The RainStick shower is a recirculating shower that saves 80% energy and 80% water but still feels like a luxurious shower.
- Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fonds de solidarité FTQ is a private equity and venture capital firm specializing in investments in start-ups, early venture, mergers, business acquisitions, management buyouts, market development project or a buyout, financing for new programs, organic growth and cash flow, growth and expansion financings, development capital, business succession,financial restructuring, business transition financing, family and non-family buyout, consolidations, turnaround, and leveraged management buyouts. It also invests in new markets, product and business line developments, market diversification, interim financings, new product marketing, additional working capital, purchase of tangible and intangible assets, equipment modernization, equipment purchases or upgrades, and integrator projects. The firm has regional funds that do not invest in retail, real estate, farming, biotechnology, and financial services. Fonds de solidarité FTQ invests in small and medium-sized businesses. It typically invests in export projects, forest products, productivity improvement, natural resources, aerospace, agri-food, wood, pulp and paper, chemicals, construction and construction materials, printing, transportation equipment and automobiles, transportation services, furniture and fixtures, combinatorial chemistry and other lead generating technologies, mining and exploration, social economy, textiles, plastics, life sciences, business services, telecommunications, distribution and consumer goods, environment, equipment and machinery, financial services, information and communication technology, metal products, recreational tourism, and culture sectors. Within the culture sector, Fonds de solidarité FTQ seeks to invest in pre-production and creative projects, production projects, infrastructures and services, post-production projects, distribution, and broadcasting and multiplatform broadcasting. Within the environment sector, it invests in waste management and energy conversion for residual waste; air treatment and reduction of greenhouse gas emissions; processes to reduce industrial energy and water consumption; water treatment; and soil rehabilitation and decontamination (metals and organic compounds). Within the life sciences sector, Fonds de solidarité FTQ focuses on services for the biopharmaceutical industry; nutraceuticals and cosmeceuticals; diagnostics and medical supplies and equipment; biopharmaceuticals and generic drugs; biotechnology, and animal health. Within the tourism sector, it focuses on urban tourism, nature tourism, resort type tourism, and local tourism for Quebecers, and in the textiles sector it invests in companies engaged in development and production of specialty textiles as well as development of industrial applications for the construction, transportation, health and safety, and work apparel industries. Fonds de solidarité FTQ prefers to invest in Quebec and in companies impacting the Québec economy. It focuses on investing in the following regions- Abitibi –Témiscamingue, Bas Saint Laurent, Chaudière-Appalaches, Côte-Nord, Estrie, Gaspésie Îles-de-la-Madeleine, Lanaudière, Laurentides, Laval, Mauricie - Centre-du-Québec, Montérégie, Nord-du-Québec, Outaouais, and Saguenay-Lac-St-Jean. Fonds de solidarité FTQ seeks to invest in projects of $3 million or more and also provides loans of up to $ 2 million. It invests in companies in business succession sector having minimum capitalization of $500,000 and EBITDA of over $35.5 million in case of majority interest; equipment and machinery sector with average investment in excess of $3 million; environment sector with funding needs of more than $500000; financial services sector having net assets between $20 million and $50 million in equity; metal products sector having annual sales of over $5 million and financing needs of at least $2 million; and printing sector having investment needs of over $1 million. In the information technology sector, Fonds de solidarité FTQ seeks to invest $2 million as initial investments while total investments can be more than $10 million. It invests in the form of equity financing (common or preferred shares) and unsecured debt requiring no collateral (debenture). Fonds de solidarité FTQ can take both a minority interest including an equity stake of up to 49 percent as well a majority interest in its portfolio companies in case of business succession financing. It seeks a minority stake for the portfolio companies in the equipment and machinery sector. It typically holds its investments for a period of five to ten years in case of equity financing and for more than ten years in case of business succession financing. Fonds de solidarité FTQ began operation on June 23, 1983. It has its headquarters in Montreal in Canada with additional offices in the same city and Quebec in the same country.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Software
- Stage:Series A, Series B
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 204
- Round size: Series A $2.2M–$62M; Series B $6M–$83M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- EBC inc — EBC is a family business founded in 1968 by Fernand Houle and his brother Germain. They built the company on their core values of respect, integrity and a job well done — values that the current president, Marie-Claude Houle, is proud to uphold. In its 45 years, EBC has carried out over 600 projects totalling more than $6 billion. FromNewfoundland and Labrador to New Brunswick, Ontario, Manitoba and British Columbia, as well as the international arena, clients have chosen EBC for our professionalism and our respect for budgets and timelines. This rigorous approach is applied to all our projects, whether building construction, civil engineering, earthworks, mining, marine works, energy transport, wind power, etc.
- JLD - Laguë — The JLD-Laguë Group, authorized John Deere dealers, specializes in the sale of agricultural, commercial and construction equipment.
- IMV Inc — IMV Inc Inc. applies its novel adjuvanting platform to the development of vaccines for cancer therapy, infectious diseases and animal health. The Company’s DepoVax™ platform is a patented formulation that provides controlled and prolonged exposure of antigens plus adjuvant to the immune system. IMV Inc has advanced two DepoVax-based cancer vaccinesinto Phase I human clinical trials. The Company is also advancing a broad infectious disease pipeline including vaccines in such indications as malaria, respiratory syncytial virus (RSV) and anthrax. In addition to the Company’s human health vaccine strategy, it continues to capture value from animal health vaccine applications. IMV Inc has key partnerships in the animal health sector including an agreement with Pfizer Animal Health.
Next-generation venture capital. Write your story with us.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series B, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 77
- Round size: Seed $3M–$23M; Pre-Seed $500k–$4M; Series B $25M–$130M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- xAI — XAI is an AI company that develops a platform to accelerate human scientific discovery. The company primarily focuses on developing advanced AI systems that are truthful, competent, and maximally beneficial for all of humanity. Its mission is to understand the true nature of the universe.
- Spiritus — Redefining direct air capture through true carbon-neutral solutions for less than $100/ton.
- Applied Intuition — Applied Intuition enables engineering and product development teams to safely develop, test, and deploy autonomous vehicles at scale.
Enabling passionate, committed SaaS entrepreneurs to accelerate growth.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series A, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 18
- Round size: Series A $7.5M–$21M; Series B $17M–$21M
- Lead/follow: 78% lead, 22% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- AppWork — We are on a mission to modernize multifamily maintenance by giving you the data you need to make informed business decisions.
- Help Lightning — Help Lightning offers remote visual guidance software for enterprises that delivers a next generation video collaboration solution for field service.
- Mentor Collective — Gain access to the research, services & technology necessary to build an inclusive culture of mentorship for all your students. Partner with Mentor Collective.
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 282
- Round size: Series A $4.7M–$80M; Series B $10M–$105M; Series C $12M–$108M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Stablix — Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.
- Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
- Lycia Therapeutics — Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
We angel invest in founders who will improve the lives of millions. Based in Toronto, Canada.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Angel
- Geography: Canada, United States
Investor stats
- Total investments: 22
- Round size: Seed $1.3M–$3.2M; Pre-Seed $120k–$1.5M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
- Spare — Spare is your all-in-one mobility operations platform, designed to provide an end-to-end platform ecosystem for operating modern paratransit and microtransit systems.
- Mayday — Time is your most valuable asset. Make sure you're spending it wisely.
The Ontario Centres of Excellence invests in projects and people to accelerate industry R&D to impact the Ontario economy through the commercialization of leading edge research.OCE invests in- Industry-Academic collaborative research- Commercialization of academic research through licensing and spin off companies- Early stage seedfinancing of start-ups- Skills development for high quality personnelThe Ontario Centres of Excellence is a not-for-profit corporation founded in 1987. Core funding is provided by the Ontario Ministry of Research and Innovation
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 150
- Lead/follow: no public data
Portfolio highlights
- Uride — Welcome to Uride - your reliable and affordable ridesharing service with a community-focus. Enjoy the ease of quick pickups, lower fares, and a user-friendly app designed to make your travels smoother. Start riding today!
- FluidAI Medical — Real-Time Monitoring for Anastomotic Leaks with Origin, by FluidAI. Early data shows FluidAI's Origin can detect leaks an average of 1.6 days earlier.
- Novel Biotechnology — Novel Biotechnology is building high-throughput bacterial platforms for the biotech industry, with a focus on plasmid DNA manufacturing.
Charles River provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B
- Geography: United States, Canada, France
Investor stats
- Total investments: 14
- Round size: Series A $20M–$31M; Series B $12M–$103M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
- Ability biologics — Ability develops innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
- Vernal Biosciences — Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.
Scale Good Fund is a Social Impact Venture Capital VC fund that invests in companies who have the promise of a strong financial return coupled with measurable social impact goals.
Show more...Investment focus
- Industry: Health Care, Wellness, Apps
- Stage:Pre-Seed, Seed
- Geography: Canada
Investor stats
- Total investments: 6
- Round size: Seed $1.5M–$5.2M; Pre-Seed $37k–$1.5M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- NiaHealth — Get advanced at-home biomarker testing, proactive healthspan diagnostics, and expert guidance to elevate your health. HSA-eligible.
- Ultimarii —
- Healthkind — Enabling healthcare teams to deliver personalized care at scale.
Pfizer Venture Investments is a corporate venture capital firm that invests in areas of current or future strategic interest to Pfizer. It aims to remain at the forefront of life science advances. It identifies and invests in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’spipeline and shape the future of its industry.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 167
- Round size: Series A $10M–$100M; Series B $20M–$123M; Series C $15M–$102M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $600M in 2018
Portfolio highlights
- Neuronetics — Antidepressant medications don't work for everyone. If drugs haven't worked for you, learn about NeuroStar - safe, effective, lasting TMS therapy for depression.
- Pyxis Oncology — Charting a course to therapeutics for difficult-to-treat cancers.
- Triana Biomedicines — Triana Biomedicines is building the leading molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high- resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas.
Desjardins Capital makes it easy to grow your business with financial and strategic support. Investment capital and venture capital can help you meet your business goals.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 135
- Round size: Seed $805k–$5M; Series A $5.7M–$22M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $120M in 2018
Portfolio highlights
- Vention — Design and order custom industrial equipment in days. Fast and easy-to-use cloud CAD, loaded with modular parts, that ship next day.
- Inscora — Inscora provides automated cyber risk assessment and sales enablement tools for cyber insurance brokers.
- Moka — Moka helps you save effortlessly by automatically investing your spare change. Get started in just a few minutes and watch your money grow with every purchase you make. Save more, spend less and invest smarter with Moka.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!LVL1 Group is a private investment management firm, operating across different asset classes and geographies. We were founded with entrepreneurial spirit at our core, with a natural passion for venture investing, working closely with founders to forge meaningful strategic relationships and helping them to succeed. We are not bound by mandates andinvestment periods, which allows us to be flexible and opportunistic. We look for companies that aim to make a strong global impact, particularly in Online Travel, Gaming, eSports, Content and Community Platforms.
Show more...Investment focus
- Industry: Software, Health Care, Apps
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 48
- Round size: Seed $577k–$10M; Series A $2M–$39M; Series B $3.7M–$26M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Appetito — Buy all your groceries and household essentials from your online supermarket. Order from the comfort of your home at your finger tips.
- GRACIA.AI — Gracia is revolutionizing spatial computing offering immersive volumetric (aka spatial) videos that provide full viewpoint freedom. This means you can step into the video and experience it from any perspective. AI-powered technology and natural parallax effects in VR enable the indistinguishable transfer of real events into the digital world,delivering a feeling of truly being there.
- Cloud Retail — Grow your business with Jiffy SaaS platform which includes app/website, picking, delivery, supply chain & replenishment services
Innovate Calgary is a central innovation hub at the University of Calgary. See our programs and fundings and learn more about our innovation hubs here.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 36
- Round size: Seed $878k–$1.9M; Pre-Seed $73k–$428k
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- MACH32 — MACH32 is a medical device startup that develops innovative solutions for new and longstanding medical problems.
- InventoRR MD — InventoRR MD focuses on commercializing groundbreaking trauma and general surgery devices that improve patient recovery outcomes, simplify procedures for doctors, and reduce costs for healthcare organizations.
- Difinity Solutions — Difinity Solutions is specializing in the development of medical devices and technology solutions.
Founded 16 years ago in 1997, it is the only Angel Capital Forum ™ in Canada that introduces emerging companies to private equity Angel Investors. Presenting companies have raised over $35 million directly through the Forum. Read this third party blog comment and video overview. Since 1998, it has offered Investor Ready ™ workshops for companies& investors.As the oldest & largest angel network in Western Canada with 50+ investors (from Vancouver, Calgary, Edmonton, Kelowna, Victoria, Bellingham and Seattle), they are supported by leading organizations in BC and belong to Canada's National Angel Capital Organization and US's Angel Capital Association. Their private meetings are exclusive to only pre-registered Investors, selected Companies and Sponsors. Regretfully no observers except volunteers.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Angel, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 15
- Round size: Seed $20k–$500k
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Cuboh — Cuboh consolidates all your food delivery orders in one tablet and integrates them with your restaurant's POS system. Cuboh, online ordering on autopilot.
- Truss — Send and receive business payments online with no limits, no percentage fees and no bullsh*t. Bring your business payments into the 21st century.
- Orbitless Drive — ORBITLESS, we are pioneering the future of gear systems with our groundbreaking drivetrain technology
Add a description for facebook
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A
- Geography: Canada, United States, Trinidad and Tobago
Investor stats
- Total investments: 42
- Round size: Seed $1.8M–$16M; Series A $5.1M–$25M
- Lead/follow: 10% lead, 90% follow
- Last fund: Likely still investing — raised $18M in 2022
Portfolio highlights
- BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
- Proof — Make Government Decisions, Better.
- Applied Brain Research — Applied Brain Research Inc is the maker of Nengo, a neuromorphic artificial intelligence interactive development environment for building neural computing applications. Neuromorphic computing is an emerging computing architecture which uses artificial neurons to compute like the brain does, massively parallel and low-power. AI networks built onneuromorphic hardware and software compute with less power and use more continuous states as opposed to discrete weight updates as machine learning algorithms do. The benefit is that applications built this way can use less power, be more responsive and more accurate. The neuromorphic architecture allows real-time integration of multiple AI networks into integrated, large, functional systems. Full-loop AI systems can be built with Nengo such as Spaun, the world's largest functional brain simulation. Spaun is ABR's research platform for full-loop service robotics. ABR is first commercializing Nengo as the compiler and runtime for the new generation of neuromorphic chips such as the Intel Loihi, Spinnaker and BrainDrop, as well as ABR's library of neuromorphic applications for these chips such as Reach for robotic reaching, Vision, Speech built on ABR's neuromorphic AI algorithms (spiking deep learning, reinforcement learning, adaptive control, ....). ABR's long run goal is to build its neuromorphic platform into a truly functional service robotic operating system, starting with ABR Reach and guided by the learnings from ABR's research into Spaun. ABR was spun out of Dr Chis Eliasmith's lab at the Center for Computation and Theoretical Neuroscience at the University of Waterloo.
StandUp Ventures is a venture capital firm investing in female-founded companies in the B2B software and digital health sector.The firm is led by a team of experienced investors who have assembled a diverse advisory committee. The advisory committee is comprised of successful founders, venture investors, and other strategic mentors who willprovide high-touch support to the entrepreneurs. StandUp Ventures catalyzes strong deal flow across Canada from its network and syndicate seed rounds with Angels and US VCs.
Show more...Investment focus
- Industry: SaaS, Software, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 40
- Round size: Seed $1.3M–$5M; Pre-Seed $731k–$2M; Series A $2.2M–$14M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $15M in 2019
Portfolio highlights
- AssistIQ — Designed for simplicity and powered by computer vision and machine learning, AssistIQ Capture accurately tracks supplies and implants as they are used...
- Indiegraf — Indiegraf provides support, assistance, and resources to independent news outlets. It offers various services to help companies or organizations start their own digital news system. Indiegraf is based in Vancouver, Canada.
- Mercator AI — Our mission is to give business developers more time to do what they do best, and support them with the insights they need to have informed and productive conversations. We mine and analyze millions of construction data points across the project lifecycle so that our customers can confidently find and qualify projects and partners faster.Mercator is used by Architecture, Engineering, Construction, Real Estate, and Manufacturing companies to inform strategic and tactical decision making.Mercator AI is a privately held company that has recently closed a pre-seed round.
Yaletown Partners specializes in investing in software, data, and device technologies. It invests in technology companies that improve industry and enterprise productivity and sustainability, to help accelerate their growth, shorten exit timeframes, and accomplish strong exit premiums.With offices in Vancouver, Calgary, Montréal, and a growingpresence in Toronto, Yaletown is led by a national team that contributes almost 100 years of technology-industry experience and a network of extensive industry relationships.
Show more...Investment focus
- Industry: Software, Manufacturing, Enterprise Software
- Stage:Series A, Series B, Seed
- Geography: Canada, United States, Belgium
Investor stats
- Total investments: 84
- Round size: Seed $603k–$4M; Series A $2.9M–$16M; Series B $2.1M–$31M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $100M in 2017
Portfolio highlights
- ePACT Network — ePACT will improve emergency preparedness across North America. By connecting every home and organization with shared information and resources, ePACT will have a positive impact on the safety of our communities. Its benefits will encourage users to adopt and share the system, while its tools help North Americans manage unexpected situations.
- Elevated Signals — Elevated Signals provides cannabis producers with user-friendly manufacturing software that combines digital batch production records, inventory tracking and environmental data into a single customizable platform. By digitizing how cannabis operations run and streamlining data collection and aggregation, the system helps businesses significantlylower costs, scale quickly and make more informed decisions.Elevated Signals is used by some of the largest producers in North America, as well as a growing wave of innovative mid-size and craft facilities. It is the fastest-growing regulated manufacturing execution and quality software company in Canada.
- Circle Cardiovascular Imaging — Explore advanced cardiovascular imaging software. Enhance diagnosis & clinical workflows with our AI-driven solutions. Contact us today!
The Atlantic Canada Opportunities Agency works to create opportunities for economic growth in Atlantic Canada by helping businesses become more competitive, innovative and productive, by working with diverse communities to develop and diversify local economies, and by championing the strengths of Atlantic Canada. Together, with Atlantic Canadians,we are building a stronger economy.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Grant, Debt Financing, Seed
- Geography: Canada, United States, France
Investor stats
- Total investments: 206
- Round size: Seed $25k–$2M; Grant $30k–$2M; Debt Financing $138k–$1.1M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- Greenii — Greenii provides recycling services for paper bags. They offer services that include newsprint paper bags, kraft paper bags, logo printing, crinkle paper shreds, and shredded cardboard.
- ReelData AI — ReelData AI provides artificially intelligent monitoring for finned fish aquaculture. It delivers weight distributions, feeding analysis, health analysis, and growth analysis
- RFINE Biomass Solutions — RFINE Biomass Solutions is to make coffee waste sustainable and delightful.
Hazelview Ventures provide entrepreneurs with a unique opportunity to refine, scale, and showcase product and service capabilities.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Big Data
- Stage:Seed, Pre-Seed
- Geography: Canada, Slovakia (Slovak Republic)
Investor stats
- Total investments: 7
- Round size: Seed $2M–$12M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Xaba — Xaba develops intelligent automation solutions, materials and processes to enable a world of sustainable manufacturing.
- Lamarr.AI — Saving Energy Through Automated Building Exterior Inspection AI-powered envelope diagnostics to accelerate the transition to Net Zero buildings. Contact Us About Lamarr.AI Defining pathways for future cities by developing technology innovations Lamarr.AI entered the market in 2023 as the product
- Augmenta Inc. — Design sustainable, code compliant and fully constructible buildings in hours.
1517 Fund is an early stage venture capital fund that supports teams led by dropouts, deep-tech scientists & founders working outside of tracked institutions.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 106
- Lead/follow: no public data
Portfolio highlights
- Cents — Cents is the #1 point of sale and business management platform for laundromats to grow, manage and understand their business. Schedule a free demo.
- Marathon Fusion — The fuel cycle for fusion energy.
- Solideon — Additive Space Technologies uses additive manufacturing systems, a machine-learning collaborative system for building vehicles and infrastructure on Earth, the Moon, or Mars.
Psychedelic Medical Intervention Investment Fund
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Post-IPO Equity, Series A
- Geography: United States, Canada, Australia
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Gilgamesh Pharmaceuticals — We develop novel medicines that harness the therapeutic promise of psychedelics to revolutionize the treatment of mental illness
- Filament Health — Filament Health is a company that uses hard extraction and drug discovery technology to get natural psychedelics into the hands of everyone who needs them as fast as possible. Filament Health has a strong natural psychedelic intellectual property portfolio based on novel extraction and purification methods.
- Betterlife Pharma — BetterLife Pharma is an emerging biotechnology company focused on developing and commercializing patient-friendly compounds to treat neuro-psychiatric and neurological disorders. Our vision is to take the fear out of psychedelics by producing non-hallucinogenic medicines that will be the solutions to treat the wide range of unmet mental health conditions like anxiety, depression, PTSD, & migraine
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Manufacturing & supply chain management: Engineered, specialty & standard fasteners, CNC precision machined components, parts for automotive, aerospace defense, & other industries
Show more...Investment focus
- Industry: Software, Aerospace, Architecture
- Stage:Seed
- Geography: Canada
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Augmenta — Design sustainable, code compliant and fully constructible buildings in hours.
SeedFolio is a seed-stage venture capital firm investing in early-stage companies with a high potential of profitable impact in life sciences and resource efficiency.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United States
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
- Vasa Therapeutics — Vasa Therapeutics is a privately held, preclinical-stage encinitas, CA-based biopharmaceutical company.
- VIAN Therapeutics — VIAN Therapeutics is an early-stage biotechnology company focused on transforming retinal disease treatment. With a first-in-class, non-invasive eyedrop as its lead product, VIAN aims to replace invasive injections for conditions like age-related macular degeneration (AMD) and diabetic macular edema (DME). Backed by strong preclinical data andongoing clinical testing, VIAN is positioned to address significant unmet medical needs and disrupt the $15 billion retinal disease market.
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, France, Canada
Investor stats
- Total investments: 197
- Lead/follow: no public data
Portfolio highlights
- Umaro Foods — Umaro Foods specializes in developing a plant-based protein source from ocean-farmed seaweed.
- TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
- Bright Peak Therapeutics — Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. At Bright Peak, they are creating innovative cytokine therapeutics that are uniquely engineered to precisely control and expand desired biological properties.
Suffolk Technologies is launching the third annual Suffolk Boost Program: an intense 6-week program to help promising startups solve their biggest business problem in the construction technology space.
Show more...Investment focus
- Industry: Construction, Software, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 40
- Lead/follow: no public data
Portfolio highlights
- Higharc — Higharc is the all-in-one web platform that simplifies, connects and improves each step of design, construction and sales for home building.
- Handle — Purpose-built for material suppliers and contractors to manage the entire process of payments and lien management.
- Ediphi — The most advanced cloud-based estimating solution.
The Ontario Bioscience Industry Organization (OBIO) is a private sector.
Show more...Investment focus
- Industry: Biopharma, Biotechnology, Medical Device
- Stage:Seed, Grant
- Geography: Canada
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Tenomix — Tenomix mission is to develop novel technologies that target inefficiencies in the pathology workflow optimize cancer care and reduce healthcare costs
- Qidni Labs — Over two million patients around the world suffer from End Stage Renal Disease (ESRD). Patients' survival depends on dialysis, a renal replacement therapy that they undergo until they receive a kidney transplant. The survival rate of patients under dialysis is less than 40% in 5 years (1).A year of dialysis of each patient may cost upwardsof $60,000 in Canada and the United States. Patients endure a lot more hardships due to complications and lifestyle restrictions. Studies show that longer treatment times can potentially be associated with prolonged survival.
- HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
Prelude Ventures invests in and supports early-stage startups with the greatest potential to mitigate climate change. For us, climate is everything.
Show more...Investment focus
- Industry: Software, Energy, Manufacturing
- Stage:Series A, Series B, Series C
- Geography: United States, Canada
Investor stats
- Total investments: 153
- Lead/follow: no public data
Portfolio highlights
- Persefoni AI — Persefoni is a Climate Management & Accounting Platform (CMAP). The company's Software-as-a-Service solutions enable enterprises and financial institutions to meet stakeholder and regulatory climate disclosure requirements with the highest degrees of trust, transparency, and ease. As the ERP of Carbon, the Persefoni platform provides usersa single source of carbon truth across their organization, enabling them to manage their carbon transactions and inventory with the same rigor and confidence as their financial transactions.
- Copper — Thoughtfully designed, meticulously engineered, well-made home electrification products.
- Ripple Foods — Ripple Foods offers a nutritious & delicious milk alternative that is 100% dairy-free, vegan, nut-, lactose- & gluten-free. Discover more about Ripple milk!
Discover Eos Bioinnovation's commitment to advancing sustainable biotechnology through innovative research and development. Explore our mission and services.
Show more...Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
- Autoimmunity BioSolutions — ABS is developing a next-generation, immuno-corrective therapy to restore normal immune function in a genetically-defined subpopulation of autoimmune disease patients.
Questa Capital is a healthcare venture capital firm that invests in breakout growth companies. We seek out disruptive business models that improve lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series B, Series C
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 41
- Lead/follow: no public data
Portfolio highlights
- ACTO — ACTO is an omnichannel education platform for life sciences companies. ACTO is an AI-powered SaaS platform built for life sciences that uses mobile experiences and agency partnerships to give learners all the tools they need in one intuitive cross-platform app, and give leaders powerful admin tools with engagement data in one command center.
- SamaCare — SamaCare helps you spend less time with prior authorizations and more time with patients - at no cost for medical practices.
- Eko Health — At Eko every digital stethoscope from Eko comes with smart disease detection capabilities to help healthcare professionals confidently identify and diagnose heart and lung disease during physical exams.
Archangel is the overarching early stage investment fund based in Waterloo Region, the North Silicon Valley of North America.
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Seed, Pre-Seed
- Geography: Canada
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Monark — At the Monark Ventures, we help great ideas live up to their fullest potential. We create, lead, and succeed.
- Requity Homes — Requity Homes Inc. is on a mission to create a fair and flexible alternative path to home ownership in Canada by offering a modernized rent-to-own program that enables aspiring home buyers to live in their dream home today with the option to buy it back later while saving for their down payment one month at a time.
- Noa Therapeutics — Defying the convention of traditional drug development to revolutionize treatment options for complex inflammatory skin diseases.
AgCapital Canada provides capital to help owner-operators take their companies to the next, higher level.
Show more...Investment focus
- Industry: AgTech, Analytics, Internet of Things
- Stage:Seed, Series A, Series B
- Geography: Canada
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Ukko Agro — Ukko Agro develops an agriculture ecosystem that helps optimize pesticide usage to minimize crop losses. It offers technology tools that facilitate on-farm decision making with minimal time investment from the growers.The company is driven to optimize pesticide use for better crop yield, by integrating technologies to track, analyze, andquantify sustainability gained. Its product features realtime on-farm monitoring, predicts disease or pest attacks, prescribe pesticide spray, integrates with external on-farm equipment and technologies, reduces crop losses, and optimizes crop inputs.Ukko Agro was founded in 2017 and is headquartered in Toronto, Ontario.
- P&P Optica — What's in your food? Do better than visual inspection! Future-proof your plant with a proven automated detection of low-density foreign materials. Book a call.
- eQcell — Canadian Regenerative Medicine Company addressing condition and diseases affecting sporting and domestic animals
Life Science VC funding in Canada at a glance
Stats across 191 deals from 249 investors.
Access all 249 VC funds in Canada Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Canada investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 249 VC funds investing in Canada Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!